{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-030972","form_type":"8-K","ticker":"XAIR","cik":"0001641631","company_name":"Beyond Air, Inc.","filed_at":"2024-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.920971+00:00","generated_at":"2026-05-31T10:24:28.309095+00:00","sec_items":["2.02","3.01","5.02","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Beyond Air reports Q1 revenue $0.7M, net loss $0.27/share; receives Nasdaq bid-price deficiency notice","bullets":["Revenue $0.7M, up 45% QoQ from $0.5M; net loss $12.2M ($0.27/share) vs $14.1M ($0.45) year ago.","Cash burn $13.1M; cash $21.4M; expects net cash burn <$30M in FY2025; breakeven target Q4 FY2026.","Nasdaq notice: bid price below $1.00 for 30 days; 180-day cure until Feb 4, 2025; may consider reverse split.","Amir Avniel appointed CEO of NeuroNOS (autism program); resigns as CBO and Board member effective Aug 15, 2024.","Revenue guidance >$10M for FY2025; commercial progress with LungFit PH in 55+ hospitals across 10 states."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-030972","json":"https://secwatch.observer/filing/0001493152-24-030972.json","markdown":"https://secwatch.observer/filing/0001493152-24-030972.md","text":"https://secwatch.observer/filing/0001493152-24-030972.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641631/000149315224030972/0001493152-24-030972-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641631/000149315224030972/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:24:28.309095+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"72e5a41da6","claim":"Amir Avniel resigned as Director at Beyond Air, Inc..","evidence_excerpt":"tendered his resignation from the board of directors of the Company and as the Chief Business Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315224030972/0001493152-24-030972-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"d95ebfcb16","claim":"Amir Avniel resigned as Chief Business Officer at Beyond Air, Inc..","evidence_excerpt":"tendered his resignation from the board of directors of the Company and as the Chief Business Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315224030972/0001493152-24-030972-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Business Officer"}],"fact_type":"executive_change"},{"claim_id":"f50c85435f","claim":"Amir Avniel was appointed as Chief Executive Officer at Beyond Air, Inc..","evidence_excerpt":"On August 6, 2024, Amir Avniel was appointed Chief Executive Officer of NeuroNOS Israel Limited overseeing the Company’s autism spectrum disorder program and tendered his resignation from the board of directors of the Company and as the Chief Business Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1641631/000149315224030972/0001493152-24-030972-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}